Kathleen Engler is a seasoned executive in the healthcare sector, renowned for her leadership and strategic acumen. With a robust background in operational management, she has successfully spearheaded initiatives aimed at optimizing service delivery within hospitals and health systems. Her expertise spans regulatory compliance, performance improvement, and patient engagement strategies that drive both quality outcomes and financial sustainability. Known for fostering cross-functional collaboration among clinical and administrative teams, Kathleen plays a pivotal role in navigating complex challenges while enhancing organizational effectiveness. As an advocate for innovative healthcare solutions, she continues to influence industry standards and improve patient care experiences.
Kathleen Engler is a seasoned executive in the healthcare sector, renowned for her leadership and strategic acumen. With a robust background in operational management, she has successfully spearheaded initiatives aimed at optimizing service delivery within hospitals and health systems. Her expertise spans regulatory compliance, performance improvement, and patient engagement strategies that drive both quality outcomes and financial sustainability. Known for fostering cross-functional collaboration among clinical and administrative teams, Kathleen plays a pivotal role in navigating complex challenges while enhancing organizational effectiveness. As an advocate for innovative healthcare solutions, she continues to influence industry standards and improve patient care experiences.
Opportunity in the healthcare sector often aligns with strategic improvements driven by leadership insights. Kathleen Engler leverages her extensive experience to identify innovative solutions that address pressing challenges in service delivery and operational efficiency. Her approach emphasizes transformative strategies, focusing on collaboration between clinical and administrative sectors to enhance patient outcomes while ensuring fiscal responsibility. This alignment of quality care with financial sustainability enables a robust platform for growth, positioning organizations favorably within an evolving market landscape. With a keen eye on regulatory developments and performance metrics, she navigates complexities adeptly, maintaining a commitment to excellence in healthcare services.
Opportunity in the healthcare sector often aligns with strategic improvements driven by leadership insights. Kathleen Engler leverages her extensive experience to identify innovative solutions that address pressing challenges in service delivery and operational efficiency. Her approach emphasizes transformative strategies, focusing on collaboration between clinical and administrative sectors to enhance patient outcomes while ensuring fiscal responsibility. This alignment of quality care with financial sustainability enables a robust platform for growth, positioning organizations favorably within an evolving market landscape. With a keen eye on regulatory developments and performance metrics, she navigates complexities adeptly, maintaining a commitment to excellence in healthcare services.
| Trades 5418 | Longs Won 2829/5418 52% | Profit Factor 3.43 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $9.78M |
| Average Win $601,660.73 | Best Trade (Dec 31) $712.37M | Sharpe Ratio -10.2 |
| Average Loss -$191,704.85 | Worst Trade (Dec 30) -$18.6M | Z-Score -14.93 (100%) |
| Commissions $0 | Avg. Trade Length 11m 1w | Expectancy $222,549.71 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | 0.01% | 0.12% | 0.59% | 2.05% | 5.7% | 13.53% | 28.61% | 55.38% |
| Consecutive Losing Trades | 6,329 | 5,696 | 5,063 | 4,430 | 3,797 | 3,165 | 2,532 | 1,899 | 1,266 | 633 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AA Alcoa Corporation | 36,036 | $2.39M | $1.47M | - | -$920,359.44 | -38.5% | 0.0 |
AAPL Apple Inc. | 90,193 | $19.82M | $30.62M | - | $10.8M | 54.46% | 0.0 |
ABBV AbbVie Inc. | 7,380 | $1.57M | $2.13M | - | $562,188.19 | 35.78% | 0.0 |
ABNB Airbnb, Inc. | 64,653 | $7.38M | $11.44M | - | $4.06M | 54.96% | 0.0 |
ABT Abbott Laboratories | 6,725 | $851,488.21 | $675,929.75 | - | -$175,558.46 | -20.62% | -1.894% |
ACB Aurora Cannabis Inc. | 33,060 | $158,418.35 | $131,248.2 | - | -$27,170.15 | -17.15% | 0.0 |
ACGL Arch Capital Group Ltd | 4,345 | $417,076.55 | $440,105.05 | - | $23,028.5 | 5.52% | 0.0 |
ACN Accenture plc Class A | 28,867 | $8.69M | $6.9M | - | -$1.79M | -20.55% | 0.0 |
ADBE Adobe Inc. | 90,538 | $32.62M | $23.24M | - | -$9.38M | -28.75% | 0.0 |
ADI Analog Devices, Inc. | 4,656 | $1.22M | $1.85M | - | $627,120.94 | 51.34% | 0.0 |
ADM Archer-Daniels-Midland Co | 6,866 | $394,726.34 | $552,438.36 | - | $157,712.02 | 39.95% | 0.0 |
AEM Agnico Eagle Mines Limited | 5,022 | $550,653.06 | $940,921.92 | - | $390,268.86 | 70.87% | +0.596% |
AER AerCap Holdings N.V. | 2,955 | $424,810.8 | $426,761.1 | - | $1,950.3 | 0.46% | 0.0 |
AFL Aflac Inc. | 3,748 | $411,193.08 | $450,771.96 | - | $39,578.88 | 9.63% | 0.0 |
AGNCO AGNC Investment Corp. 10.1219% Perpetual Preferred Stock | 23,609 | $590,212.54 | $590,697.18 | - | $484.64 | 0.08% | 0.0 |
AGX Argan Inc. | 5,030 | $1.58M | $1.76M | - | $175,749.75 | 11.1% | 0.0 |
AIG American International Group Inc. | 5,208 | $445,544.4 | $426,431.04 | - | -$19,113.36 | -4.29% | 0.0 |
ALB Albemarle Corporation | 2,281 | $349,782.81 | $215,486.07 | - | -$134,296.74 | -38.39% | -1.357% |
ALC Alcon Inc. | 20,794 | $1.84M | $1.41M | - | -$425,237.3 | -23.16% | 0.0 |
ALL Allstate Corporation | 3,254 | $698,449.17 | $813,207.14 | - | $114,757.97 | 16.43% | 0.0 |